|Study Period:||2018 - 2026|
|Fastest Growing Market:||Asia Pacific|
|Largest Market:||North America|
Need a report that reflects how COVID-19 has impacted this market and its growth?
The infection control market is projected to register a CAGR of 6.5% during the forecast period (2021-2026).
The infection control market is primarily driven by the high prevalence of nosocomial infections and the growing number of surgeries that require control measures to stop spreading. According to the Centers for Disease Control and Prevention (CDC), about one in every 20 patients admitted for the treatment will develop a nosocomial infection. Hospital-acquired infections result in more than 99,000 deaths each year. The lack of awareness regarding infection control and stringent regulatory requirements are anticipated to impede market growth. However, the government and non-government organizations' initiatives regarding infection control, coupled with the growing control measures by the healthcare providers in hospitals, are expected to drive the market growth. For instance, in January 2020, The Ministry of Health and Population has launched the second phase of Infection Control Initiatives in nine governorates of Egypt.
Scope of the Report
Infection control products and services are concerned with the prevention or control of the infection in health-care settings, such as laboratories, hospitals, and others.
|By Products and Services|
|Endoscope Reprocessing Products|
|Other Infection Control Products|
|Hospitals and Clinics|
|Medical Device Companies|
|Other End Users|
Key Market Trends
Sterilization Products and Services are Anticipated to Have Significant Share
Sterilization is important to control infectious diseases that may exist everywhere in hospitals or healthcare facilities, and it is debatable whether antibiotics can control such an extensive attack.
The sterilization products and services segment under the product and services segment is anticipated to have lucrative growth owing to the increasing need to reduce hospital-acquired infection and extensive use of sterilization equipment in the healthcare settings. According to the World Health Organization (WHO), at least 30 new diseases emerged in the last 20 years, and infectious diseases kill 17 million people every year.
Moreover, an increasing number of surgeries, increasing prevalence of infectious diseases, and growth in the healthcare industry are anticipated to boost the market growth over the forecast period.
In the end-user segments, the hospital is anticipated to have a significant growth due to the increasing adoption of infection control products due to increasing number of patient suffering from COVID-19 and stringent regulations by the respective governments to control the infections.
To understand key trends, Download Sample Report
North America is Expected to Witness Significant Growth
North America is anticipated to have the significant growth owing to well-established healthcare infrastructure, high adoption of infection control technologies, and the presence of the key market players in the region. Furthermore, the initiatives are taken by the government authorities in infection control and recent product launches. For instance, Getinge AB has launched a new 9100E Cart Washer in the United States for the healthcare industry.
On the other hand, the Asia Pacific region is anticipated to have lucrative market growth due to the growing healthcare industry, increasing disposable income, and expanding healthcare providers' investments in infection control. Moreover, infection control initiatives and the growing number of hospital-acquired infections in the region are anticipated to boost the market growth over the forecast period.
To understand geography trends, Download Sample Report
The global infection control market is moderately fragmented and competitive. Market players are focusing on new product launches, product innovations, and geographical expansion to strengthen its market share. The key market players operating in the market include Fortive (Advanced Sterilization Products), 3M Company, Getinge AB, Steris PLC, and Cantel Medical Corporation.
in August 2021, Advanced Sterilization Products, a Fortive company, launched the STERRAD VELOCITY, a biological Indicator (BI)/process challenge device (PCD) in the Asia Pacific region.
In June 2021, Nanosonics announced to launch Nanosonics AuditPro, a new infection prevention digital product platform.
Table of Contents
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidence of Chronic Diseases Along with Increasing Geriatric Population
4.2.2 Technological Advancements and Increasing Outsourcing of Sterilization Services
4.3 Market Restraints
4.3.1 Lack of Awareness Regarding Infection Control
4.3.2 Stringent Regulatory Requirements along with Concerns for the Safety of Reprocessed Instruments
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Products and Services
5.1.1 Sterilization Products and Services
188.8.131.52 Sterilization Equipment
184.108.40.206.1 Heat Sterilization Equipment
220.127.116.11.2 Low-Temperature Sterilization Equipment
18.104.22.168.3 Radiation Sterilization
22.214.171.124.4 Other Products and Services
126.96.36.199 Contract Sterilization Services
188.8.131.52 Consumables and Accessories
5.1.2 Cleaning and Disinfection Products
184.108.40.206.1 Hand Disinfectants
220.127.116.11.2 Surface Disinfectants
18.104.22.168.3 Skin Disinfectants
22.214.171.124.4 Other Disinfectants
126.96.36.199 Cleaning and Disinfection Equipment
188.8.131.52 Consumables and Accessories
5.1.3 Protective Barriers
184.108.40.206 Surgical Drapes
220.127.116.11 Surgical Gowns
18.104.22.168 Other Protective Barriers
5.1.4 Endoscope Reprocessing Products
5.1.5 Other Infection Control Products
5.2 By End-User
5.2.1 Hospitals and Clinics
5.2.2 Medical Device Companies
5.2.3 Pharmaceutical Companies
5.2.4 Other End Users
5.3.1 North America
22.214.171.124 United States
126.96.36.199 United Kingdom
188.8.131.52 Rest of Europe
184.108.40.206 South Korea
220.127.116.11 Rest of Asia-Pacific
5.3.4 Middle East and Africa
18.104.22.168 South Africa
22.214.171.124 Rest of Middle East and Africa
5.3.5 South America
126.96.36.199 Rest of South America
6. COMPETITIVE LANDSCAPE
*List Not Exhaustive
6.1 Company Profiles
6.1.2 Fortive Corporation
6.1.3 Belimed AG (Metall Zug)
6.1.4 Cantel Medical Corporation
6.1.5 Getinge AB
6.1.6 MELAG Medizintechnik GmbH & Co. KG
6.1.7 Danaher Corporation (Metrex Research, LLC)
6.1.8 MMM Group
6.1.9 Sotera Health LLC
6.1.10 STERIS plc.
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Infection Control Market market is studied from 2018 - 2026.
What is the growth rate of Infection Control Market?
The Infection Control Market is growing at a CAGR of 6.5% over the next 5 years.
Which region has highest growth rate in Infection Control Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Infection Control Market?
North America holds highest share in 2021.
Who are the key players in Infection Control Market?
Fortive (Advanced Sterilization Products), 3M Company, Getinge AB, Steris PLC, Cantel Medical Corporation are the major companies operating in Infection Control Market.